Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Chronic Pancreatitis
  • Age: Between 18 Year(s) - 99 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Chronic pancreatitis
    2. Scheduled for endoscopic therapy for ductal obstruction (may include lithotripsy, pancreatic duct dilation, or stone extraction to facilitate successful stenting) as part of routine clinical care
    3. Pain present for = 3 days per week for = 3 months;
    4. Average abdominal pain over the last week = 4 on a scale from 0 (no pain) – 10 (worst pain imaginable))

You may not be eligible for this study if the following are true:

    1. Episode of acute pancreatitis within 2 months of enrollment;
    2. Endoscopic therapy that is deemed to be technically successful by the endoscopist including ERCP, EUS Guided Celiac Plexus Block or pancreatic surgery < 3 months prior to enrollment;
    3. Active illicit drug use (excludes marijuana use);
    4. American Society of Anesthesiologists classification > 3;
    5. Immune-mediated pancreatitis or associated pancreatic neoplasms
    6. Major neurological disease such as stroke, uncontrolled epilepsy, dementia
    7. Diagnosis of schizophrenia
    8. Chronic benzodiazepine use. Use of short acting benzodiazepine on as needed basis is acceptable if participant can stop taking benzodiazepine prior to EEG recording.
    9. Pregnancy



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.